1.

Record Nr.

UNINA9910457240003321

Autore

Click Rick L

Titolo

Business process outsourcing [[electronic resource] ] : the competitive advantage / / Rick L. Click, Thomas N. Duening

Pubbl/distr/stampa

Hoboken, N.J., : John Wiley & Sons, c2005

ISBN

1-280-26551-5

9786610265510

0-471-70097-5

Descrizione fisica

1 online resource (257 p.)

Altri autori (Persone)

DueningThomas N

Disciplina

658.4/058

Soggetti

Contracting out

Electronic books.

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Description based upon print version of record.

Nota di bibliografia

Includes bibliographical references (p. 223-231) and index.

Nota di contenuto

Business Process Outsourcing; contents; foreword; preface; acknowledgments; Part One: BPO Overview; Chapter 1: What Is So Revolutionary about BPO?; BPO: A SOCIO-TECHNICAL INNOVATION; DRIVING FACTORS; BPO TYPES; TO BPO OR NOT TO BPO? A STRATEGIC QUESTION; SUMMARY; Chapter 2: Who Is Using BPO and How?; SUCCESSFUL OFFSHORE OUTSOURCING; COMPETENCE CO-DEVELOPMENT OUTSOURCING; VARIABLE-PRICE OUTSOURCING; FIRST-TIME OUTSOURCING; REVERSE OUTSOURCING; BUSINESS TRANSFORMATION OUTSOURCING; UNSUCCESSFUL OFFSHORE OUTSOURCING; CONCLUSION; SUMMARY; Part Two: To BPO or Not to BPO?

Chapter 3: Identify and Select the BPO Opportunity BPO PROJECT TEAM STRUCTURE; SIX-STEP PROCESS; STEP 1: ESTABLISH A BPO ANALYSIS TEAM; STEP 2: CONDUCT A CURRENT STATE ANALYSIS; STEP 3: IDENTIFY CORE AND NONCORE ACTIVITIES; STEP 4: IDENTIFY BPO OPPORTUNITIES; STEP 5: MODEL THE BPO PROJECT; STEP 6: DEVELOP AND PRESENT THE BUSINESS CASE; CONCLUSION; SUMMARY; Chapter 4: Identify and Manage the Costs of BPO; TOTAL COST MANAGEMENT; FINANCIAL COSTS; STRATEGIC COSTS; CONCLUSION; SUMMARY; Part Three: BPO Vendor Selection; Chapter 5: Identify and Select a BPO Vendor; AN EIGHT-STEP PROCESS



STEP 1: APPOINT A VENDOR SELECTION TEAM STEP 2: ESTABLISH QUALIFICATIONS; STEP 3: DEVELOP A LONG LIST; STEP 4: REQUEST FOR INFORMATION; STEP 5: REQUEST FOR PROPOSALS; STEP 6: EVALUATE THE PROPOSALS; STEP 7: SELECT A SHORT LIST; STEP 8: SELECT THE VENDOR; CONCLUSION; SUMMARY; Chapter 6: BPO Contracts; NEGOTIATING BPO AGREEMENTS; TERMS OF THE BPO CONTRACT; CONCLUSION; SUMMARY; Part Four: Executing an Outsourcing Project; Chapter 7: Managing the BPO Transition; THE BPO PROJECT MANAGEMENT PLAN; GENERAL PRINCIPLES OF CHANGE MANAGEMENT; CONCLUSION; SUMMARY

Chapter 8: Managing the Buyer - Vendor Relationship FUNDAMENTAL CHARACTERISTICS OF THE BPO PROJECT; BPO RELATIONSHIP SUCCESS FACTORS; RELATIONSHIP RISK FACTORS; CONCLUSION; SUMMARY; Chapter 9: Infrastructure Considerations and Challenges; HARDWARE INFRASTRUCTURE; SOFTWARE INFRASTRUCTURE; KNOWLEDGE INFRASTRUCTURE; TRAINING AND SUPPORT INFRASTRUCTURE; CONCLUSION; SUMMARY; Chapter 10: Business Risks and Mitigation Strategies; HUMAN CAPITAL RISKS; PROJECT RISKS; INTELLECTUAL PROPERTY RISKS; LEGAL RISKS; VENDOR ORGANIZATIONAL RISKS; VALUE RISKS; FORCE MAJEURE RISKS; CONCLUSION; SUMMARY

Part Five: The Future of BPO Chapter 11: Future Potential for BPO; GLOBAL BUSINESS ENVIRONMENT; STRATEGY AND COMPETITIVENESS; BPO AND POLITICS; BPO AND GLOBAL ECONOMICS; BPO AND GLOBAL WORKERS; BPO AND EDUCATION; OUTRAGEOUS PREDICTIONS: WHAT'S LEFT FOR AMERICA?; CONCLUSION; endnotes; Index

Sommario/riassunto

Business Process Outsourcing (BPO) is becoming the new revolution as company's of all sizes are seeking to take advantage of this source of competitive advantage.This book provides a step-by-step approach to understanding the application of Business Process Outsourcing, assessing the BPO opportunity in the company, and then managing the transition to BPO. It serves as a guide to implementing BPO and as a reference source to solving the variety of issues that may arise during a BPO initiative. Each chapter features a case study, insight from a practitioner, focus on how BPO affects people,



2.

Record Nr.

UNINA9910557382703321

Autore

Riessland Markus

Titolo

Cellular Senescence in Health, Disease and Aging: Blessing or Curse?

Pubbl/distr/stampa

Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021

Descrizione fisica

1 online resource (112 p.)

Soggetti

Biology, life sciences

Research and information: general

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Sommario/riassunto

Dear Colleagues, When Hayflick and Moorhead coined the term "cellular senescence" (CS) almost 60 years ago, this phenomenon was understood as a mechanism, usually induced by activation of the DNA-repair machinery, to prevent uncontrolled proliferation. Meanwhile, additional beneficial roles for CS have been identified, such as embryonic development and wound healing. The senescence associated secretory phenotype (SASP) activated in most senescent cells (SC) signals to the immune system "come here and remove me". In organisms with young and functional immune systems, occurring SC are usually detected and removed. If SC remain in the tissue expressing the SASP, this will cause not just a damaging local inflammation but can also induce remodeling and regeneration of the surrounding tissue as well as spreading of senescence. Old organisms show reduced regenerative potential and immune function which leads to accumulation of SC. Accordingly, accumulation of SC was observed in tissues of aged individuals, but importantly also in the context of age-related disorders, neurodegenerative, or cardiovascular diseases and others. Because of its detrimental effect of the surrounding tissue, accumulation of SC is not just a consequence, but can rather been understood as a major driver of aging. In line with this, recent studies described that removal of SC showed beneficial effects on healthspan



and lifespan. This exciting research led to the discovery of "senolytics", drugs which can kill SC. Given the heterogeneity of cell types that show senescence-like phenotypes, including heart muscle and post-mitotic neuronal cells, further research is required to unravel the molecular background that renders a cell type vulnerable to senesce. Additionally, it will be important to understand how senescence is cell type-specifically induced and which molecules serve as drug targets to prevent senescence and its spreading, or actively kill SC. This special issue will shed light on the molecular pathways of CS and inflammaging and on possible strategies to interfere with these processes. Dr. Markus Riessland Guest Editor